Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy

Size: px
Start display at page:

Download "Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy"

Transcription

1 Graefe s Arch Clin Exp Ophthalmol (2004) 242: CLINICAL INVESTIGATION DOI /s Cynthia A. Toth Deborah J. Lapolice Avie D. Banks Sandra S. Stinnett Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy Received: 9 September 2003 Revised: 7 January 2004 Accepted: 8 January 2004 Published online: 5 June 2004 Springer-Verlag 2004 C. A. Toth ()) D. J. Lapolice A. D. Banks S. S. Stinnett Department of Ophthalmology, Duke University Medical Center, Box 3802, Durham, NC 27701, USA toth004@mc.duke.edu Tel.: Fax: C. A. Toth Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA S. S. Stinnett Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA Abstract Background: Information is limited on how specific near-vision skills are impacted by therapies such as macular translocation surgery with 360-degree retinectomy (MT360) for age-related macular degeneration (AMD). Methods: Standardized tests of near vision were given to 25 consecutive patients with AMD who met entry criteria for this study, preoperatively and 6 and 12 months after MT360. Tests included: near acuity with the Lighthouse chart, timed reading speed using Sloan cards, contrast sensitivity, and color vision. Distance acuity was measured using Bailey Lovey charts. Measures of preoperative visual function were analyzed to identify those predictive of visual outcomes. Results: Distance acuity was 20/80 or better in 52% of patients at 12 months after surgery, and mean acuity improved from ~20/125 preoperatively to ~20/100 at 12 months. Mean near acuity improved from M before surgery to M at 12 months (significant change of Ÿ1.5 2 M, P<0.001). Gain of greater than five numbers in contrast sensitivity at 12 months was also significant (P<0.001). Mean reading speed improved from words per minute (wpm) before surgery to wpm at 12 months (significant gain of wpm, P=0.001). Preoperative distance acuity, near acuity, and reading speed were each predictors of postoperative near visual function. Conclusion: Standardized testing of near visual function provides important predictive and functional outcome data for MT360. MT360 significantly improved near visual function (including near acuity, reading speed and contrast sensitivity) in patients with subfoveal lesions from AMD in the second eye. Introduction Near visual function, that is the ability to see items at near and to read, is highly valued in our society, as demonstrated in studies of low vision and quality of life. Reading is the primary rehabilitation goal of patients with low vision and central field loss [7, 10, 13, 14, 21]. In questionnaires, patients equate near visual functioning and perceived reading ability to perceptions of a visual disability [10, 18]. Reading ability has a significant positive correlation with quality of life, and reading speed has been shown to be the most important factor for general visual quality of life [10]. Numerous measures have been used to assess near visual function in patients with low vision and with agerelated macular degeneration (AMD) [3]. Testing of near visual function has covered a wide range of abilities, recognition of from single letters and numbers to reading ability in a variety of print sizes. Despite the range of available near-vision tests, there is limited information on how specific near-vision skills are impacted by therapies for AMD. Clinical trials of treatments for AMD, notably the Macular Photocoagulation Study (MPS) and the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy study, have not reported outcomes in terms of reading speed or using other tests of near visual

2 542 function. The Submacular Surgery Trials (SST), sponsored by the National Eye Institute, included tests of reading speed in study patients with subfoveal choroidal neovascularization or hemorrhage [22]. This study used as a measure the time to read single-size, large-print text cards of approximately 17.5-meter text, equating to a distance acuity of approximately 20/1500 (personal communication with Barbara Hawkins, SST Headquarters). The SST is ongoing, and the near-vision results have not yet been reported. Macular translocation surgery with 360-degree peripheral retinectomy (MT360) was first reported by Robert Machemer in 1992 at the Club Jules Gonin in Vienna, Austria. The reported goal of macular translocation surgery was to recover central acuity by moving the macula away from the region of subfoveal pathology. In the early series of patients reported by Machemer, some patients recovered distance and near vision, although there was a high rate of retinal detachment and proliferative vitreoretinopathy [16]. Numerous surgeons have subsequently modified and varied the Machemer technique for the treatment of patients with choroidal neovascular membranes beneath the macula and vision loss [6, 9, 12]. Claus Eckardt in 1999 reported improvement in reading ability in a majority of patients who were treated with MT360 [6]. Lai et al. reported a significant improvement in near acuity at 6 months and a tendency towards improvement in reading speed that was not significant (using SST large-print reading cards) after MT360 in a series of 15 patients in the Duke Macular Translocation Study [12]. Fujikado et al. reported a significant improvement in critical print size after MT360, although the change in reading speed was not significant [9]. Clearly there is a limitation of the large-print cards for testing the reading function in macular translocation patients, and there is a need for comprehensive evaluation of macular function, including acuity, reading speed with near print tests, color vision, and contrast sensitivity before and after MT360 surgery. We therefore utilized standardized tests for these factors, including reading ability and near visual function, in a series of 25 patients in the Duke Macular Translocation Study. In this prospective non-randomized study of patients with central vision loss in the second eye due to subfoveal choroidal neovascularization, we analyzed the impact of MT360 on the results of multiple tests of visual function and evaluated the utility of these tests in predicting postoperative visual function. Methods Twenty-five consecutive patients participating in an IRB-approved study of macular translocation surgery at Duke University Medical Center who met the entry criteria for this study participated in the evaluation of near vision recovery. The patients entered the study between October 2000 and July Eligibility criteria for the macular translocation surgery study included, AMD and the loss of vision in the fellow eye due to CNV or disciform scar. The treatment eye was required to have: 1. Subfoveal neovascular AMD with no previous subfoveal laser or previous ocular photodynamic therapy 2. Lesion components including classic CNV, occult or combination of classic and occult CNV with no limit to the amount of subretinal hemorrhage, RPE atrophy, pigment epithelial detachment or subretinal fibrosis 3. No chorioretinal anastomosis 4. Duration of vision loss less than 6 months 5. Best-corrected Snellen acuity worse than 20/60 before study entry At examinations before operation, 6 months postoperatively, and 1-year after operation, the patients had complete vision testing including distance and near acuity. Distance visual acuity was measured using the SST protocol and using the retro-illuminated Bailey Lovey charts under standard illumination conditions [12]. Testers of postoperative vision were not masked to the preoperative results, though the previous data sheets were not available to the tester at the time of testing. Near acuity testing was performed in a single setting with standard illumination using the Lighthouse near card (Lighthouse, New York, NY) with add over distance correction. Text size was reported in meters of text (e.g., 10 meters or 1.0 meter) measured on the card. This lsize of text was then provided to the patient in the form of a continuous-text Sloan reading card in order to measure reading speed at the patient s preferred focal distance, still using the add correction. Additionally, the patients were asked whether they were functionally reading at home ; for example, they were asked to specify whether they were able to read books, magazines, or mail. Contrast sensitivity was measured using the LEA near-contrast cards (Precision Vision, La Salle, IL) in which contrast becomes lower with each number on the chart. The grading for contrast sensitivity was by number count, ranging from zero numbers read correctly to a top score of 30 numbers. Color vision was assessed using the PV16 discs (Precision Vision). The color test results were categorized into the following grades: grade 5, all 16 discs in correct order; grade 4, three or fewer discs incorrectly placed by one place; grade 3, one color family, but fewer than five discs, incorrect; grade 2, two color families incorrect with fewer than six discs incorrect; grade 1, more then two color families incorrect but at least three discs correct; grade 0, all plates incorrect. The patients also underwent fluorescein angiography at each study visit. The lesion sizes and components were assessed from the fluorescein angiograms using MPS disc area rings measuring 1, 2, 3, 3.5, 4, 5, 6, 9, 12, and 16 MPS disc areas [17]. The sizes of lesions greater than 16 MPS disc areas were estimated using several rings. Patients also completed quality of life evaluations and underwent optical coherence tomography pre- and postoperatively. Analysis of quality of life and optical coherence tomography data will be reported separately. Statistical methods Initially, descriptive statistics (n and percentage for categorical variables; n, mean, standard deviation, median, minimum, and maximum for continuous variables) were obtained and displayed. Change from baseline to 6 months and to 1 year was computed for distance and near visual acuity, reading speed, color, and contrast. The significance of the change was assessed using the Wilcoxon signed ranks test. Spearman rank correlation was computed to assess the relationship between the values of these variables at

3 543 baseline and their values at 6 months and at 1 year. In addition, linear regression was used to assess the individual predictive abilities of each preoperative measure (distance and near visual acuity, reading speed, color, contrast, duration of lesion, and size of lesion) for postoperative visual acuities and reading speed (at 6 months and at 1 year). The ranks of both predictor and dependent variables were used in the regression analyses. McNemar s test was used to assess the agreement between 6-month and 1-year outcomes in preferred eye and ability to read. Results There were 16 females and 9 males in this study, with a median age of 77 years (range years). The median duration of vision loss was 6 weeks, with a range of 1 24 weeks. The preoperative median visual acuity in the fellow eye was 20/320, with a range of 20/50 to 20/8000. All patients had a history of AMD and all had a choroidal neovascular membrane beneath the fovea in the treatment eye. The mean lesion size was 8 MPS disc areas (~2900 mm), with classic CNV comprising greater than 50% of the lesion in 20% of eyes. All patients participated in the 6-month follow-up testing, and 24 of 25 patients returned for 1-year followup testing. One patient did not return for 1-year follow-up due to inability to travel. Her local ophthalmologist provided a written report of Snellen distance acuity of 20/40 in the treated eye at 1 year after MT360. Because her 1- year Snellen acuity was the same as her acuity at 6-month standardized testing at Duke, for data analysis, her 6- month distance acuity score was brought forward for the 1-year data point. Near acuity was not formally tested at her 1-year outside examination, and thus it was not included in the 1-year analysis. The patient reported an ability to read using her 6-month-old reading glasses at home at 1 year. Mean distance acuity for the 25 patients was letters (20/125 Snellen standard deviation) preoperatively and letters 6 months postoperatively, and improved to letters (20/100 Snellen) at 1 year after MT360 (Fig. 1). The mean change in distance acuity was a gain of letters at 6 months after MT360 and a gain of letters at 1 year. This change from the preoperative acuity was not significant (P=0.89 for 6 months and P=0.32 for 1 year; Wilcoxon signed ranks test). At 1 year, 28% of patients had gained 20 or more letters of acuity in the operated eye, 12% had gained 5 14 letters of acuity, 24% remained within 4 letters of preoperative acuity, 28% had lost 5 14 letters of acuity, 8% had lost letters of acuity, and 0% had lost more than 18 letters of acuity. Distance visual acuity was greater than or equal to 20/80 in 44% of patients preoperatively, 48% of patients at 6 months, and 52% of patients at 1 year after MT360. Near visual acuity before and after MT360 is summarized in Fig. 2. Using the meter (M) scale for near Fig. 1 Distance acuity before surgery is compared to 1 year after macular translocation 360 surgery. Distance acuity was measured using the Bailey Lovey chart; thus, the scale is number of letters correctly read. Fifty letters is equivalent to approximately 20/200 Snellen acuity. The improvement in distance acuity was not significant Fig. 2 Near acuity before surgery is compared to 1 year after MT360 surgery. Near acuity recorded in Meter print size, using Lighthouse near cards and add over best correction for distance visual acuity (a large number corresponds to a larger letter size). The improvement in near acuity was significant at 1 year (P<0.001) acuity, a large number corresponds to a larger letter size. The mean near acuity in the 25 patients was M before surgery and had improved to M by 6 months; it improved to M in the 24 patients tested at 1 year after MT360. The mean change in near acuity was Ÿ M at 6 months and Ÿ M at 1 year. The change in near visual acuity was significant both at 6 months and at 1 year (P<0.001; Wilcoxon signed ranks test).

4 544 Fig. 3 Reading speed before surgery is compared to 1 year after MT360 surgery. Reading speed recorded as words per minute at near using Sloan cards and add over best refraction for distance. Improvement in reading speed was significant at 1 year (P=0.001) Fig. 4 Contrast sensitivity before surgery is compared to 1 year after MT360 surgery. Contrast sensitivity recorded at near using LEA contrast cards and add over best refraction for distance. Improvement in contrast sensitivity was significant at 1 year (P<0.001) Fig. 5 Color vision grade using the PV-16 color discs before surgery is compared to 1 year after MT360 surgery. The improvement in color vision at 1 year was not significant (P=0.12) The results of testing reading speed with a add over distance correction are summarized in the graph Fig. 3. The average reading speed in the 25 patients was words per minute (wpm) before surgery and improved to wpm at 6 months; it improved to wpm in the 24 patients tested at 1 year after MT360. Reading speed at 6 months improved by wpm, and at one year improved by wpm. This change in reading speed was statistically significant at 6 months (P=0.013) and 1 year (P=0.001) (Wilcoxon signed ranks test). Before MT360 surgery, 32% of patients read over 40 wpm, but only 16% of patients read more than 70 wpm. At 6 months after surgery, 56% of patients read over 40 wpm and 32% read over 70 wpm. At 1 year after surgery, 67% read over 40 wpm and 38% read over 70 wpm. By self-report, 88% of patients preferred the treatment eye for visual functioning before and 1 year after MT360 surgery. Before surgery only 16% of patients reported being able to read at home, whereas postoperatively 64% at 6 months and 80% at 1 year reported being able to read at home. There was a statistically significant increase in the proportions of patients able to read at the two time points (P<0.001; McNemar s test for agreement). All patients who could read before surgery continued reading at 6 and 12 months after MT360. Of the 21 patients who could not read preoperatively, 12 patients at 6 months and 16 patients at 1 year were able to read. Contrast sensitivity results are seen in Fig. 4. The mean number of contrast numbers correctly read by the 25 patients was before surgery and increased to numbers at 6 months; the 24 patients tested at 1 year correctly read numbers. Contrast sensitivity gained by numbers at 6 months and numbers at 1 year. The change in contrast sensitivity was statistically significant at both 6 months and 1 year (P<0.001; Wilcoxon signed ranks test). Color vision results are seen in Fig. 5. The mean color vision score by PVS 16 color vision grade was before surgery. It improved to in the 25 patients tested at 6 months after surgery and to in the 24 patients tested at 1 year after surgery. The change in color vision was not significant at either 6 months or 1 year (P=0.09 for 6 months and P=0.12 for 1 year; Wilcoxon signed ranks test). At 1 year, no patient had dropped by more than one color group; 25% of patients had lost one

5 545 color group, 33% maintained the same color group score, and 42% gained by one to three color groups. Preoperative distance visual acuity, near visual acuity and reading speed were predictive of postoperative vision outcomes. Significant predictors of distance visual acuity at 1 year were preoperative measures of distance acuity (P=0.011, positive direction) and near acuity (P=0.006, negative direction: note that only in the scale used for near vision, a lower grade was assigned to better acuity). Thus, better preoperative distance or near acuity predicted better postoperative distance visual acuity. Significant predictors of near visual acuity at 1 year were preoperative measures of distance acuity (P<0.001, negative direction), near acuity (P<0.001, positive direction), and reading speed (P=0.027, negative direction). Thus, better preoperative distance or near acuity or reading speed predicted better postoperative near acuity. Significant predictors of reading speed at 1 year were preoperative measures of distance acuity (P=0.007, positive direction), near acuity (P=0.011, negative direction), and reading speed (P=0.031, positive direction). Thus, better preoperative distance acuity, near acuity, and reading speed predicted better postoperative reading speed. The preoperative color vision grade, contrast sensitivity score, lesion size, and duration of vision loss were not significant predictors of distance visual acuity, near visual acuity, or reading speed at 1 year. Preoperative reading speed was not a significant predictor of distance visual acuity at 1 year. In this series, the following complications occurred: 28% of patients had cystoid macular edema found on either fundus examination, fluorescein angiography, or optical coherence tomography; 36% had recurrent choroidal neovascularization, with extension into the fovea in 20%; 28% had epiretinal membrane. Three patients had at least one subretinal droplet of perfluorocarbon liquid, although none was in the fovea; and no patient had a macular fold. There were two retinal detachments involving the inferior retinal margin without macular detachment. Both patients had surgical repair of the retinal detachment. Both retinal detachments were identified after silicone oil was removed. Discussion Eckardt et al. in 1999 were the first to report reproducible improvement in distance and near acuity and reading ability after MT360 surgery [6]. In that retrospective review and in other studies of MT360, near visual function was ascertained by direct observation or by noting the report of the patient as to whether he or she could read [1, 2, 6, 19] Lai et al. [12] and Fujikado et al. [9] studied the impact of MT360 surgery on distance and near acuity and reading speed, using standardized tests of distance acuity (Bailey Lovey Charts, Lai et al.; Landolt Cs, Fujikado et al.), near acuity (Jaeger cards, Lai et al.; Landolt Cs, Fujikado et al.) and reading speed (SST large print cards, Lai et al.; Japanese version of the Minnesota reading chart, Fujikado et al.) before and after MT360. Both groups found no significant change in distance acuity and in reading speed after MT360. However, they each found a significant improvement in one measure of near acuity. Fujikado et al., in AMD patients from 4 to 15 months after surgery, found a significant improvement in critical print size after MT360. Lai et al. found significant improvement in near acuity at 6 months after MT360. In the present small prospective non-randomized series of patients subsequent to the Lai series, we have shown a beneficial effect of MT360, with improvement in distance and near acuity in the majority of patients. These outcomes are an improvement over the earlier report of Toth and Freedman, most likely due to the improvement in surgical techniques and the surgeons extended experience since the earlier study [22]. Moreover, in the current study, we have also detailed the improvements in multiple aspects of near visual function after MT360, including reading speed, contrast sensitivity, and color vision. In this study, the improvements in near visual acuity, contrast sensitivity, and reading speed were statistically significant. These patients also reported an improvement in ability to read at home that was consistent with the improvement in near vision measured in our clinic. These data support the hypothesis that MT360 surgery can shift the sensory retina away from dysfunctional support tissue and onto an adequate bed of choroid and RPE with recovery of central visual function. In the clinical experience of one author (D.J.L.), as well as in published studies on near vision testing, central visual field loss is associated with poor reading ability defined by significant decreases in reading speed [8, 13]. Many ocular factors affect the reading speed, including print size, contrast, field of view, and size and location of scotoma [8, 13, 14, 21, 25]. The scotoma location is a major factor for macular degeneration patients, since reading rates are reduced severely when a scotoma is centered on the fovea. These rates are also significantly reduced when a scotoma is displaced either to the left or right of the fovea. Patients with central scotomas adopt eccentric viewing behaviors, and their reading rates decrease to about 25% of those in scotoma-free conditions [13]. Maximum reading speed in peripheral vision is limited by the reduced number of characters that can be recognized in a glance (visual span). Chung et al. reported that visual span decreases from 10 characters in central vision to 2.8 characters at 15 deg eccentric to central fixation) [5]. Further studies showed that reading speed of greater than 80 wpm is not possible using eccentric fixation with the presence of a central scotoma. Whittaker and Lovie- Kitchin reported that 160 wpm is a high fluent rate for reading, 80 wpm is fluent, and 40 wpm is adequate only

6 546 for spot reading [25]. Using the 40-wpm standard, our patients improved from only 32% spot reading preoperatively to over 67% spot reading at 1 year. It is interesting to compare this to the self-reported ability to read at home, with 16% reading preoperatively and 80% reading at 1 year. We believe that the improvement in near visual function, particularly the ability to read after macular translocation surgery, is due to resolution of density or extent of the central scotoma once the macular photoreceptors are positioned over the new healthier RPE choriocapillaris bed. In the present study, the improvement in reading speed and contrast sensitivity, the proportion of patients with a good postoperative reading speed, and the small print size that these patients could read all support the premise of improvement in macular function and decrease in central scotoma after macular translocation surgery. Microperimetry studies, not performed in these patients, would better define the evolution of central and paracentral scotomas affecting reading speed. We have subsequently initiated use of microperimetry in studies of macular translocation surgery patients, to better understand the impact of scotoma density and location on visual function. Other measures of retinal function, such as electroretinography (ERG), were not performed in our study. Other researchers have addressed ERG changes after macular translocation surgery. Lüke et al. evaluated photopic and scotopic ERG of 32 patients before and after MT360 [15]. (Note that they used a calcium- and magnesium-free solution to detach the retina during surgery). In their series, the mean logmar visual acuity had decreased by only 0.13 at the time of the approximately 6- month postoperative ERG (not a significant change), but amplitudes of both a- and b-waves for both photopic and scotopic ERG were reduced. The authors proposed that surgical techniques or the calcium- and magnesium-free infusion solution might relate to the diminished ERG amplitudes in their series. Terasaki et al. also found diminished ERG amplitudes after MT360 in a series of 15 patients, all of whom had improved acuity after MT360 [23]. The negative impact of AMD on cone function and thus on color vision has been measured, although treatments of AMD to date have not had a notable impact on color vision function [4, 11, 20]. In this study, there was a trend toward improvement in color vision after the macular photoreceptors were relocated off the pathologic lesion, with 42% of patients gaining one to three color groups after surgery. The small number of patients in our series, however, and the large steps in the color vision grading scale, limit our ability to identify small changes in color vision function. The improvements in near acuity, reading speed, and contrast sensitivity after MT360 surgery appear to be greater than the distance improvement. A likely explanation for this difference in near visual function relative to distance acuity is the very complex interaction between the density, location, and size of a central scotoma, color vision, and contrast sensitivity and the reading speed. As numerous researchers have shown, each of these factors has an impact on near function and reading ability [3, 4, 5, 8, 10, 13, 14, 18, 19, 21, 25]. It is unclear why the improvement in distance acuity is less than that in near acuity after MT360. In addition to the above factors, the extraocular muscle surgery may cause some limitation in microsaccades utilized in reading the distance ETDRS chart. The level of distance and near acuity at 1 year, and the paucity of severe vision loss after MT360, also supports the premise that MT360 is a reasonable therapeutic option for patients losing vision in the second eye from large subfoveal CNV. In addition to the improvement in near visual function reported above, after surgery, 48% and 52% of patients achieved a distance visual acuity of 20/80 or better at 6 months and 1 year respectively. Fewer than 8% of patients lost more than 3 lines of distance visual acuity and no patient lost more than 4 lines of distance visual acuity. These results are particularly notable as they were achieved in patients with mean acuity of 20/125 and subfoveal lesion size of 8 MPS disc areas at study entry. Complications of the challenging macular translocation surgery are numerous, including retinal detachment, macular edema, and recurrence of CNV, but patients generally had a significant improvement in near visual function despite these challenges. The number of patients in this study was too small to identify any specific complications that might have affected the visual outcomes. There were two macula-sparing inferior retinal detachments in this series of 25 patients (8%). Retinal detachment was not associated with poorer visual acuity in this series. Future improvements in surgery may decrease the likelihood of such complications and/or improve their management, and thus would be anticipated to improve visual outcomes. It is important to identify factors that aid in predicting outcomes after MT360 surgery as these factors could be utilized by a surgeon to predict more accurately the likelihood of good visual outcomes for a patient. After evaluating the impact of preoperative factors on visual outcomes, we found that both preoperative near and distance visual acuity predicted postoperative near and distance acuity and reading speed in our series; in contrast, preoperative reading speed was predictive only of postoperative near acuity and reading speed. Patients with very poor near and distance acuity and reading speed were thus less likely to exhibit good postoperative visual function. These predictive relationships may be due to the association of these factors with the severity and extent of photoreceptor damage before surgery. More extensive or

7 547 severe damage would be reflected in poorer preoperative scores and might be associated with less photoreceptor recovery after translocation to a healthier RPE bed and thus result in a lower likelihood for good postoperative visual function. Alternatively, poor preoperative scores may also reflect greater preoperative scarring between the submacular lesion and photoreceptors. Thus, poor preoperative scores might predict a greater likelihood for photoreceptor injury with surgical separation of the retina from the subretinal lesion. We had also hypothesized that the preoperative color vision grade and contrast sensitivity score might predict macular function and thus identify patients likely to have a good visual outcome. These two factors, however, did not predict reading speed or near or distance acuity outcomes in this series. While these factors may genuinely not affect such outcomes, our sample size may also have been too small and the gradations in measurement for these factors may have been too large to identify any impact. Duration of vision loss by patient report, and the lesion size measured from the preoperative fluorescein angiogram, also did not predict the acuity or reading speed after surgery. We believe that improvement in functional near visual acuity is achievable after macular translocation surgery with 360 peripheral retinectomy in patients treated by a team experienced in this surgical technique. This study was performed without a control group. Future randomized studies comparing this treatment to current regimens utilized for eligible patients with bilateral severe macular degeneration will clarify the relative impact of this treatment on a patient group severely impaired by this ocular disease. Information gained from the recovery of visual function after translocation of the neurosensory retina to a healthier choriocapillaris and RPE bed may add to our understanding of the impact of scotoma density and location upon useful vision recovery. This information may also aid in identifying relative photoreceptor versus RPE contribution to the progression of vision loss in AMD, and in designing non-translocation techniques for retinal recovery, such as repopulating healthy RPE beneath the macula. Acknowledgements The authors would like to thank Katrina P. Winter, Mikki R. O Neal and Michelle N. McCall for their assistance in manuscript preparation, data gathering, and data analysis. This work was supported in part by the generous donations of the Andrew Family Foundation (Boston, MA) and Euan and Angelica Baird (New York, NY). References 1. Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87(5): Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, Thumann G,Fricke J, Neugebauer A, Hilgers RD, Esser P, Walter P, Bartz-Schmidt KU (2002) Macular translocation with 360 degree retinotomy for exudative agerelated macular degeneration. Arch Ophthalmol 120(4): Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL (1988) Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol 106: Bowman KJ (1980) The relationship between color discrimination and visual acuity in senile macular degeneration. Am J Optom Physiol Opt 57(3): Chung ST, Mansfield JS, Legge GE (1998) Psychophysics of reading. XVIII. The effect of print size on reading speed in normal peripheral vision. Vis Res 38: Eckardt C, Eckardt U, Conrad HG (1999) Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin and Exp Ophthalmol 237: Elliott DB, Trukolo-Ilic M, Strong JG, Pace R, Plotkin A, Bevers P (1997) Demographic characteristics of the vision-disabled elderly. Invest Ophthalmol Vis Sci 38: Fine EM, Rubin GS (1999) Reading with central field loss: number of letters masked is more important than the size of the mask in degrees. Vis Res 39(4): Fujikado T, Asonuma S, Ohji M, Kusaka S, Hayashi A, Ikuno Y, Kamei M, Oda K, Tano Y (2002) Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol 134(6): Hazel CA, Petre KL, Armstrong RA, Benson BT, Frost NA (2000) Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol and Vis Sci 41(6): Holz FG, Gross-Jendroska M, Eckstein A, Hogg CR, Arden GB, Bird AC (1995) Colour contrast sensitivity in patients with age-related Bruch s membrane changes. Ger J Ophthalmol 4(6): Lai JC, Lapolice DJ, Stinnett SS, Meyer CH, Arieu LM, Keller MA, Toth CA (2002) Visual outcomes following macular translocation with 360 peripheral retinectomy. Arch Ophthalmol 120: Legge GE, Rubin GS, Pelli DG, Schleske MM (1985) Psychophysics of reading. II. Low vision. Vision Res 25: Legge GE, Ross JA, Isenberg LM, LaMay JM (1992) Psychophysics of reading: clinical predictors of low vision reading speed. Invest Ophthalmol Vis Sci 33(3): Lüke C, Aisenbrey S, Lüke M, Marzella G, Ulrich Bart-Schmidt K, Walter P (2001) Electrophysiological changes after 360 degree retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 85:

8 Machemer R, Steinhorst UH (1993) Retinal separation, retinotomy, and macular relocation. II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol 231: Macular Photocoagulation Study Group (1991) Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 109: McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U (2000) Macular degeneration: do conventional measurements of impaired visual function equate with visual disability. Br J Ophthalmol 84: Pertile G, Claes C (2002) Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 134(4): Phipps JA, Guymer RH, Vingrys AJ (2003) Loss of cone function in agerelated maculopathy. Invest Ophthalmol Vis Sci 44(5): Raasch TW, Rubin GS (1993) Reading with low vision. J Am Optom Assoc 64: Submacular Surgery Trials (SST) Manual of Procedures. (1998) Springfield, VA: National Technical Information Services; NTIS Order Number PB Terasaki H, Miyake Y, Suzuki T, Niwa T, Piao CH, Suzuki S, Nakamura M, Kondo M (2002) Change in full-field ERGs after macular translocation surgery with 360 degree retinotomy. Invest Ophthalmol Vis Sci 43(2): Toth CA, Freedman SF (2001) Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina 21(4): Whittaker SG, Lovie-Kitchin J (1993) Visual requirements for reading. Optom Vis Sci 70:54 65

CLINICAL SCIENCES. Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy

CLINICAL SCIENCES. Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy CLINICAL SCIENCES Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy James C. Lai, MD; Deborah J. Lapolice, MS; Sandra S. Stinnett, DrPH; Carsten H. Meyer, MD; Luz M. Arieu,

More information

Title: Macular Translocation Surgery for Patients with Age-Related Macular Degeneration: Clinical and Cost-Effectiveness Review

Title: Macular Translocation Surgery for Patients with Age-Related Macular Degeneration: Clinical and Cost-Effectiveness Review Title: Macular Translocation Surgery for Patients with Age-Related Macular Degeneration: Clinical and Cost-Effectiveness Review Date: 08 November 2007 Context and Policy Issues: In North America, age-related

More information

Case selection in macular relocation surgery for age related macular degeneration

Case selection in macular relocation surgery for age related macular degeneration 186 SCIENTIFIC REPORT Case selection in macular relocation surgery for age related macular degeneration D Wong, P Stanga, M Briggs, P Lenfestey, E Lancaster, K K Li, K S Lim, C Groenewald... Background:

More information

SHORT COMMUNICATION. and development of visual acuity. Methods: We have retrospectively

SHORT COMMUNICATION. and development of visual acuity. Methods: We have retrospectively Graefe s Arch Clin Exp Ophthalmol (2004) 242:350 354 SHORT COMMUNICATION DOI 10.1007/s00417-003-0825-3 Ameli Gabel-Pfisterer Jessica Laue Heinrich Heimann Claudia Jandeck Ulrich Kellner Norbert Bornfeld

More information

CLINICAL SCIENCES. Consistency Between Visual Acuity Scores Obtained at Different Test Distances

CLINICAL SCIENCES. Consistency Between Visual Acuity Scores Obtained at Different Test Distances CLINICAL SCIENCES Consistency Between Visual Acuity Scores Obtained at Different Test Distances Theory vs Observations in Multiple Studies Li Ming Dong, PhD; Barbara S. Hawkins, PhD; Marta J. Marsh, MS

More information

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration Subgroup Analysis of the MARINA Study of in Neovascular Age-Related Macular Degeneration David S. Boyer, MD, 1 Andrew N. Antoszyk, MD, 2 Carl C. Awh, MD, 3 Robert B. Bhisitkul, MD, PhD, 4 Howard Shapiro,

More information

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses Graefe s Arch Clin Exp Ophthalmol (2004) 242:368 376 CLINICAL INVESTIGATION DOI 10.1007/s00417-003-0844-0 Rufino M. Silva José R. Faria de Abreu António Travassos José G. Cunha-Vaz Stabilization of visual

More information

VERTEPORFIN IN PHOTODYNAMIC THERAPY STUDY GROUP

VERTEPORFIN IN PHOTODYNAMIC THERAPY STUDY GROUP Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration: Two-year Results of a Randomized Clinical Trial Including Lesions With Occult With No Classic Choroidal

More information

Macular Translocation With 360 Retinotomy for Exudative Age-Related Macular Degeneration

Macular Translocation With 360 Retinotomy for Exudative Age-Related Macular Degeneration CLINICAL SCIENCES Macular Translocation With 360 Retinotomy for Exudative Age-Related Macular Degeneration Sabine Aisenbrey, MD; Bart A. Lafaut, MD; Peter Szurman, MD; Salvatore Grisanti, MD; Christoph

More information

SUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR

SUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR The following are summaries of selected presentations and posters from the American Society of Retina Specialists and European VitreoRetinal Society Annual Meeting held September 9 13, 2006, in Cannes,

More information

CLINICAL SCIENCES. Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration

CLINICAL SCIENCES. Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration CLINICAL SCIENCES Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration Three-Year Results of an Open-Label Extension of 2 Randomized Clinical Trials TAP Report

More information

Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo Mori,* Hiroyuki Shimada* and Izumi Utsunomiya

Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo Mori,* Hiroyuki Shimada* and Izumi Utsunomiya Surgical Excision Versus Laser Photocoagulation for Subfoveal Choroidal Neovascular Membrane with Age-related Macular Degeneration: Comparison of Visual Outcomes Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo

More information

Contrast Sensitivity and Reading: Assessment and Reliability with the Reading Explorer (REX) Test

Contrast Sensitivity and Reading: Assessment and Reliability with the Reading Explorer (REX) Test Contrast Sensitivity and Reading: Assessment and Reliability with the Reading Explorer (REX) Test Giacomelli G 1, Volpe R, Virgili G 1, Farini A 2, Arrighi R 2,Barbieri C, Menchini U 1 1. Department of

More information

Prior Authorization Review Panel MCO Policy Submission

Prior Authorization Review Panel MCO Policy Submission Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.

More information

Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration

Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration Marilita M. Moschos Abstract- Purpose: To evaluate by OCT and mf-erg the macular function in eyes with CNV due to ARMD

More information

Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy?

Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy? European Journal of Ophthalmology / Vol. 18 no. 4, 2008 / pp. 591-594 Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy?

More information

CLINICAL SCIENCES. Transplantation of Autologous Iris Pigment Epithelium After Removal of Choroidal Neovascular Membranes

CLINICAL SCIENCES. Transplantation of Autologous Iris Pigment Epithelium After Removal of Choroidal Neovascular Membranes CLINICAL SCIENCES Transplantation of Autologous Iris Pigment Epithelium After Removal of Choroidal Neovascular Membranes Gabriele Thumann, MD; Sabine Aisenbrey, MD; Ulrich Schraermeyer, PhD; Bart Lafaut,

More information

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Retina Conference Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Subjective CC/HPI: 64 year old Caucasian female referred by outside ophthalmologist

More information

A Comparison of Macular Translocation with Patch Graft in Neovascular Age-Related Macular Degeneration MATERIALS AND METHODS.

A Comparison of Macular Translocation with Patch Graft in Neovascular Age-Related Macular Degeneration MATERIALS AND METHODS. A Comparison of Macular Translocation with Patch Graft in Neovascular Age-Related Macular Degeneration Fred K. Chen, 1,2 Praveen J. Patel, 1,2 Gurmit S. Uppal, 1 Gary S. Rubin, 1,2,3 Peter J. Coffey, 2

More information

Original Policy Date

Original Policy Date MP 9.03.08 Photocoagulation of Macular Drusen Medical Policy Section Miscellaneous Policies Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return

More information

Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials

Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials Glenn J. Jaffe, MD, 1 Daniel F. Martin, MD, 2 Cynthia A. Toth, MD, 1 Ebenezer Daniel, MPH, PhD,

More information

The Natural History of Occult Choroidal Neovascularisation Associated With Age-related Macular Degeneration. A Systematic Review

The Natural History of Occult Choroidal Neovascularisation Associated With Age-related Macular Degeneration. A Systematic Review Review Article 145 The Natural History of Occult Choroidal Neovascularisation Associated With Age-related Macular Degeneration. A Systematic Review Antonio Polito, 1 MD, Miriam Isola, 2 MHS, Paolo Lanzetta,

More information

Myopic Choroidal Neovascularization

Myopic Choroidal Neovascularization Myopic Choroidal Neovascularization A 10-year Follow-up Takeshi Yoshida, MD, Kyoko Ohno-Matsui, MD, Kenjiro Yasuzumi, MD, Ariko Kojima, MD, Noriaki Shimada, MD, Soh Futagami, MD, Takashi Tokoro, MD, Manabu

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Last Review: September 2016 Next Review: September 2017 Related Policies 6.01.10 Stereotactic Radiosurgery and Stereotactic Body Radiotherapy 8.01.10 Charged-Particle (Proton

More information

Abstract Aims To analyse the histopathology of classic and occult choroidal neovascular membrane surgical specimens in age

Abstract Aims To analyse the histopathology of classic and occult choroidal neovascular membrane surgical specimens in age Br J Ophthalmol 2000;84:239 243 239 ORIGINAL ARTICLES Clinical science Clinicopathological correlation in exudative age related macular degeneration: histological diverentiation between classic and occult

More information

Dry AMD: the regulatory view

Dry AMD: the regulatory view EMA Ophthalmology Workshop 2011 Dry AMD: the regulatory view Marco Coassin, MD PhD University of Rome Campus Bio-Medico - Italy In this presentation Personal views Previous scientific advices No currently

More information

INTRODUCTION METHODS. Trans Am Ophthalmol Soc 2005;103:98-107

INTRODUCTION METHODS. Trans Am Ophthalmol Soc 2005;103:98-107 VITRECTOMY FOR THE TREATMENT OF SUBMACULAR HEMORRHAGES FROM MACULAR DEGENERATION: A COMPARISON OF SUBMACULAR HEMORRHAGE/MEMBRANE REMOVAL AND SUBMACULAR TISSUE PLASMINOGEN ACTIVATOR ASSISTED PNEUMATIC DISPLACEMENT

More information

연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과

연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과 연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과 40 Table. Clinical characteristics and results of patients undergoing photodynamic therapy for retinal angiomatous proliferation Patients No. Age/ sex Eye

More information

FEEDER VESSEL TREATMENT

FEEDER VESSEL TREATMENT THERAPEUTIC OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Donald J. D'Amico, MD Dr D Amico: The overview articles in this monograph highlight findings from clinical trials

More information

HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR

HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR HAEMORRHAGE. Stephen A.M. De Souza MD, FRCSC Matthew J Welch MD, Raza M Shah MD, Alan

More information

EPIDEMIOLOGY. with vision loss caused by age-related macular degeneration

EPIDEMIOLOGY. with vision loss caused by age-related macular degeneration EPIDEMIOLOGY Relative Contributions of Reduced Vision and General Health to NEI-VFQ Scores in Patients With Neovascular Age-Related Macular Degeneration Päivi H. Miskala, PhD; Neil M. Bressler, MD; Curtis

More information

Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration

Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration Clinical Medicine Journal Vol. 4, No. 4, 2018, pp. 60-66 http://www.aiscience.org/journal/cmj ISSN: 2381-7631 (Print); ISSN: 2381-764X (Online) Photodynamic Therapy for Treatment of Subfoveal Choroidal

More information

Despite our growing knowledge of the

Despite our growing knowledge of the OVERVIEW OF AVAILABLE TREATMENTS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Carl D. Regillo, MD ABSTRACT Although potential treatments for neovascular age-related macular degeneration represent

More information

London Medicines Evaluation Network Review

London Medicines Evaluation Network Review London Medicines Evaluation Network Review Evidence for initiating intravitreal bevacizumab for the management of wet age-related macular degeneration (wet-amd) in eyes with vision better than 6/12 November

More information

AGE-RELATED MACULAR DEGENERATION IS THE LEADing

AGE-RELATED MACULAR DEGENERATION IS THE LEADing Photodynamic Therapy for Age-related Macular Degeneration in a Clinical Setting: Visual Results and Angiographic Patterns RUTH AXER-SIEGEL, MD, RITA EHRLICH, MD, YUVAL YASSUR, MD, IRIT ROSENBLATT, MD,

More information

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May BRAND NAME Lucentis GENERIC NAME ranibizumab MANUFACTURER Genentech, Inc. DATE OF APPROVAL June 30, 2006 PRODUCT LAUNCH DATE July 13, 2006 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review of

More information

Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea

Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea Purpose: To investigate the factors that affect final vision following photodynamic therapy

More information

Clinical Trials Related to Age Related Macular Degeneration

Clinical Trials Related to Age Related Macular Degeneration Clinical Trials Related to Age Related Macular Degeneration Kirti Singh MD, DNB, FRCS Kirti Singh MD, DNB, FRCS, Pooja Jain MBBS, Nitasha Ahir MBBS, Divya Jain MD, DNB Guru Nanak Eye Centre, Maulana Azad

More information

A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration

A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration Clinical and Economic Impact Omesh P. Gupta, MD, MBA, Gary Shienbaum, MD, Avni H. Patel, MD, Christopher Fecarotta,

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

Initial Experience of Macular Translocation in Singapore One-year Results

Initial Experience of Macular Translocation in Singapore One-year Results Case Report 641 Initial Experience of Macular Translocation in Singapore One-year Results KG Au Eong, 1 M Med (Ophth), FRCS (Edin & Glas), FAMS (Ophth) Abstract Introduction: This paper reports the 1-year

More information

Although photocoagulation and photodynamic PROCEEDINGS PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION *

Although photocoagulation and photodynamic PROCEEDINGS PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION * PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Evangelos S. Gragoudas, MD ABSTRACT In December 24, the US Food and Drug Administration (FDA) approved pegaptanib sodium. Pegaptanib

More information

Sorsby's pseudoinflammatory macular dystrophy

Sorsby's pseudoinflammatory macular dystrophy British Journal of Ophthalmology, 1981, 65, 859-865 Sorsby's pseudoinflammatory macular dystrophy A. HOSKIN, K. SEHMI, AND A. C. BIRD From the Department of Clinical Ophthalmology, Institute of Ophthalmology,

More information

Intraocular Radiation Therapy for Age-Related Macular Degeneration

Intraocular Radiation Therapy for Age-Related Macular Degeneration Medical Policy Manual Medicine, Policy No. 134 Intraocular Radiation Therapy for Age-Related Macular Degeneration Next Review: April 2019 Last Review: June 2018 Effective: August 1, 2018 IMPORTANT REMINDER

More information

The legally binding text is the original French version

The legally binding text is the original French version The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 12 September 2007 INFRACYANINE 25 mg/10 ml, powder and solvent for solution for injection 25 mg vial with one 10 ml

More information

The limited number of currently approved

The limited number of currently approved CLINICAL TRIALS OF VERTEPORFIN AND PEGAPTANIB: WHAT ARE THE RESULTS? * William F. Mieler, MD ABSTRACT Currently available treatment options for the management of choroidal neovascularization (CNV) in age-related

More information

Christiane I Falkner-Radler, 1 Ilse Krebs, 1 Carl Glittenberg, 1 Boris Povazay, 2 Wolfgang Drexler, 2 Alexandra Graf, 3 Susanne Binder 1

Christiane I Falkner-Radler, 1 Ilse Krebs, 1 Carl Glittenberg, 1 Boris Povazay, 2 Wolfgang Drexler, 2 Alexandra Graf, 3 Susanne Binder 1 1 The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery, Department of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria 2 Biomedical Imaging Group, Department of Optometry

More information

CENTRAL SEROUS CHORIORETINOPATHY (CSC) IS

CENTRAL SEROUS CHORIORETINOPATHY (CSC) IS Association Between the Efficacy of Half-Dose Photodynamic Therapy With Indocyanine Green Angiography and Optical Coherence Tomography Findings in the Treatment of Central Serous Chorioretinopathy MASSIMO

More information

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation Br J Ophthalmol 2001;85:173 178 173 King s College Hospital, Denmark Hill, London SE5 9RS, UK R S B Newsom J C McAlister M Saeed J D A McHugh Correspondence to: Mr R S B Newsom, Department of Vitreoretinal

More information

Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease

Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease 8:00 AM Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease Albert M. Maguire, MD OBJECTIVE Assess maintenance of functional vision/visual

More information

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why?

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why? Original Article Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why? Dr Sreelekha S. MS, DNB, DO, FRCS, Dr Manoj Soman DNB, FICO, FRCS, Dr. Unni Nair MS, FRCS, Dr. Ruminder

More information

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing

More information

ISPUB.COM. Photopsia post flu: A case of MEWDS. S Baisakhiya, S Dulani, S Lele INTRODUCTION CASE HISTORY

ISPUB.COM. Photopsia post flu: A case of MEWDS. S Baisakhiya, S Dulani, S Lele INTRODUCTION CASE HISTORY ISPUB.COM The Internet Journal of Ophthalmology and Visual Science Volume 8 Number 1 Photopsia post flu: A case of MEWDS S Baisakhiya, S Dulani, S Lele Citation S Baisakhiya, S Dulani, S Lele. Photopsia

More information

Focal Macular Electroretinograms after Intravitreal Injections of Bevacizumab for Age-Related Macular Degeneration

Focal Macular Electroretinograms after Intravitreal Injections of Bevacizumab for Age-Related Macular Degeneration Retina Focal Macular Electroretinograms after Intravitreal s of Bevacizumab for Age-Related Macular Degeneration Eiji Iwata, Shinji Ueno, Kohei Ishikawa, Yasuki Ito, Ruka Uetani, Chang-Hua Piao, Mineo

More information

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features

More information

Clinical Features of Bilateral Acute Idiopathic Maculopathy

Clinical Features of Bilateral Acute Idiopathic Maculopathy Clinical Features of Bilateral Acute Idiopathic Maculopathy Toru Nakazawa,, Katsuhiro Yamaguchi, Masahiko Shimura, Madoka Yoshida, Yuki Yoshioka and Makoto Tamai Department of Ophthalmology, Katta General

More information

Amblyopia: is visual loss permanent?

Amblyopia: is visual loss permanent? 952 Ophthalmology and Vision Science, Queen s University, Royal Victoria Hospital, Belfast BT 12 6BA M K El Mallah U Chakravarthy P M Hart Corrrespondence to: Usha Chakravarthy u.chakravarthy@qub.ac.uk

More information

Key words: Choroidal neovascularisation, Laser coagulation, Retinal imaging

Key words: Choroidal neovascularisation, Laser coagulation, Retinal imaging 420 Mini Review The Role of Optical Coherence Tomography (OCT) in the Diagnosis and Management of Retinal Angiomatous Proliferation (RAP) in Patients with Age-related Macular Degeneration Antonio Polito,

More information

AGE-RELATED EYE DISEASE

AGE-RELATED EYE DISEASE CLINICAL SCIENC Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity AREDS Report No. 14

More information

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Fawwaz Al Mamoori* Medical Retina Department, Eye Specialty Hospital,

More information

I n the Western world, age related macular degeneration

I n the Western world, age related macular degeneration 207 SCIENTIFIC REPORT Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy F Gelisken, B A Lafaut, W Inhoffen, M Voelker, S Grisanti, K U Bartz-Schmidt...

More information

Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015

Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015 Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) in Thai Population Presenting with Choroidal Neovascularization (CNV) A multicenter study Authors Yonrawee Piyacomn 1, Chavakij Bhoomibunchoo 1, Yosanan

More information

doi: /j.ajo

doi: /j.ajo doi: 10.1016/j.ajo.2008.02.011 -Okamoto et al 1-1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Vision-related quality of life and visual function after retinal detachment surgery Fumiki Okamoto,

More information

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14.

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14. High-Speed Ultrahigh-Resolution OCT of Bruch s Membrane in Membranoproliferative Glomerulonephritis Type 2 Mehreen Adhi, MD, Sarah P. Read, MD, PhD, Jonathan J. Liu, PhD, James G. Fujimoto, PhD, and Jay

More information

Intraocular Radiation Therapy for Age-Related Macular Degeneration

Intraocular Radiation Therapy for Age-Related Macular Degeneration Intraocular Radiation Therapy for Age-Related Macular Degeneration Policy Number: 9.03.20 Last Review: 9/2014 Origination: 9/2008 Next Review: 9/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Fundamentals of Retina Coding

Fundamentals of Retina Coding Fundamentals of Retina Coding Presented by: Joy Woodke, COE, OCS Sunday, April 2, 2017 ASRS Business of Retina Meeting Dallas, TX American Academy of Ophthalmic Executives Financial Disclosure Joy Woodke,

More information

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

ZEISS AngioPlex OCT Angiography. Clinical Case Reports Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy

More information

CLINICAL SCIENCES. Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration

CLINICAL SCIENCES. Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration CLINICAL SCIENCES Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration A Series of 104 Cases of Retinal Angiomatous Proliferation Ferdinando Bottoni, MD; Amedeo Massacesi,

More information

Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage

Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage Published online: September 15, 2015 2015 The Author(s) Published by S. Karger AG, Basel 1663 2699/15/0063 0328$39.50/0 This article is licensed under the Creative Commons Attribution-NonCommercial 4.0

More information

Common Causes of Vision Loss

Common Causes of Vision Loss Common Causes of Vision Loss Learning Objectives To identify the most common causes of vision loss in the United States To differentiate the most common forms of agerelated macular degeneration and diabetic

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment

More information

OCT Angiography in Primary Eye Care

OCT Angiography in Primary Eye Care OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central

More information

NEOVASCULAR AGE-RELATED MACULAR DEGENERation

NEOVASCULAR AGE-RELATED MACULAR DEGENERation Randomized, Double-Masked, -Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2 PREMA ABRAHAM, HUIBIN YUE, AND LAURA WILSON PURPOSE: To evaluate efficacy

More information

Intravitreal Injection of Ranibizumab for Recovery of Macular Function in Eyes With Subfoveal Polypoidal Choroidal Vasculopathy

Intravitreal Injection of Ranibizumab for Recovery of Macular Function in Eyes With Subfoveal Polypoidal Choroidal Vasculopathy Retina Intravitreal Injection of Ranibizumab for Recovery of Macular Function in Eyes With Subfoveal Polypoidal Choroidal Vasculopathy Ken Ogino, Akitaka Tsujikawa, Kenji Yamashiro, Sotaro Ooto, Akio Oishi,

More information

When Retina is not detached anymore. Alexandra Mouallem, Agnès Glacet-Bernard Service du Professeur Souied Le 19/03/2014

When Retina is not detached anymore. Alexandra Mouallem, Agnès Glacet-Bernard Service du Professeur Souied Le 19/03/2014 When Retina is not detached anymore, Agnès Glacet-Bernard Service du Professeur Souied Le 19/03/2014 Medical History Mr V. 57 yo man December 2013 : Bullous superior retinal detachment caused by 2 retinal

More information

The MP-1 Microperimeter Clinical Applications in Retinal Pathologies

The MP-1 Microperimeter Clinical Applications in Retinal Pathologies The MP-1 Microperimeter Clinical Applications in Retinal Pathologies Nelson R. Sabates, MD Director, Retina/Vitreous Service Vice-Chairman Department of Ophthalmology University of Missouri Kansas City

More information

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to

More information

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan Long-term Management of AMD Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan DEFINITION 1 Age-related macular degeneration (AMD) is a disorder of the macula characterized

More information

Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration

Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration Clinical and Epidemiologic Research Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration Dennis A. Revicki, 1 Anne M.

More information

Photocoagulation of disciform macular lesions

Photocoagulation of disciform macular lesions British Journal of Ophthalmology, 1979, 63, 669-673 Photocoagulation of disciform macular lesions with krypton laser A. C. BIRD AND R. H. B. GREY From the Institute of Ophthalmology, Moorfields Eye Hospital,

More information

C horoideraemia is an X linked, recessively inherited,

C horoideraemia is an X linked, recessively inherited, 658 CLINICAL SCIENCE Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia M Flynn Roberts, G A Fishman, D K Roberts, J R Heckenlively, R G Weleber, R J Anderson,

More information

Clinical Policy Title: Ocular photodynamic therapy (OPDT) with Visudyne (verteporfin) for macular degeneration treatment

Clinical Policy Title: Ocular photodynamic therapy (OPDT) with Visudyne (verteporfin) for macular degeneration treatment Clinical Policy Title: Ocular photodynamic therapy (OPDT) with Visudyne (verteporfin) for macular degeneration treatment Clinical Policy Number: 10.02.04 Effective Date: January 1, 2016 Initial Review

More information

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation Murat Dogru, Makoto Nakamura, Masanori Inoue and Misao Yamamoto Department of Ophthalmology, Kobe

More information

THE OCULAR histoplasmosis

THE OCULAR histoplasmosis CLINICAL SCIENCES Reactivation of Inflammatory Lesions in Ocular Histoplasmosis David Callanan, MD; Gary E. Fish, MD, JD; Rajiv Anand, MD Background: Active inflammation has not been traditionally associated

More information

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Thomas Jefferson University Jefferson Digital Commons Wills Eye Institute Papers Wills Eye Institute 4-1-2008 Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related

More information

Spontaneous Large Serous Retinal Pigment Epithelial Tear

Spontaneous Large Serous Retinal Pigment Epithelial Tear This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

Supplementary Appendix

Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Edwards TL, Jolly JK, MacLaren RE, et al.. N Engl J Med 206;374:996-8. DOI: 0.056/NEJMc50950

More information

Retinal pigment epithelial detachments in the elderly:

Retinal pigment epithelial detachments in the elderly: British Journal of Ophthalmology, 1985, 69, 397-403 Retinal pigment epithelial detachments in the elderly: classification and outcome A G CASSWELL, D KOHEN, AND A C BIRD From Moorfields Eye Hospital, City

More information

A prospective nonrandomized clinical study on exudative age related macular degeneration

A prospective nonrandomized clinical study on exudative age related macular degeneration Original Article A prospective nonrandomized clinical study on exudative age related macular degeneration Ayakutty Muni Raja, Siddharam Janti, Charanya Chendilnathan, Adnan Matheen Department of Ophthalmology,

More information

Fluorescein Angiography

Fluorescein Angiography Last revision: October 2011 by Luis Arias Fluorescein Angiography Authors: Luis Arias, MD Hospital Universitari de Bellvitge - University of Barcelona. Spain Jordi Monés, MD Institut de la Màcula i de

More information

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 So What Parts of the Eye Retina are Affected by VHL Neural tissue

More information

A Study on Amsler s Grid in Acquired Macular Disorders

A Study on Amsler s Grid in Acquired Macular Disorders Ophthalmology Research: An International Journal 6(3): 1-7, 2016; Article no.or.28850 ISSN: 2321-7227 SCIENCEDOMAIN international www.sciencedomain.org A Study on Amsler s Grid in Acquired Macular Disorders

More information

The neovascular maculopathies, including age-related

The neovascular maculopathies, including age-related Retinal Changes after Retinal Translocation Surgery with Scleral Imbrication in Dog Eyes Atsushi Hayashi, 1 Shinichi Usui, 1 Kiyotomi Kawaguchi, 1 Sayuri Fujioka, 1 Shunji Kusaka, 1 Takashi Fujikado, 2

More information

A retrospective nonrandomized study was conducted at 3

A retrospective nonrandomized study was conducted at 3 Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,

More information

Ophthalmology Macular Pathways

Ophthalmology Macular Pathways Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #14 (NQF 0087): Age-Related Macular Degeneration (AMD): Dilated Macular Examination National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Vitrectomy for Diabetic Cystoid Macular Edema

Vitrectomy for Diabetic Cystoid Macular Edema Vitrectomy for Diabetic Cystoid Macular Edema Yukihiro Sato, Zeon Lee and Hiroyuki Shimada Department of Ophthalmology, Nihon University School of Medicine, Tokyo, Japan Purpose: We evaluated visual outcomes

More information

OCT Assessment of the Vitreoretinal Relationship in CSME

OCT Assessment of the Vitreoretinal Relationship in CSME December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction

More information

Running title: Long term outcome after RPE-choroid graft

Running title: Long term outcome after RPE-choroid graft Title: Long term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration Running title: Long term outcome after

More information

Focal Macular ERGs in Eyes after Removal of Macular ILM during Macular Hole Surgery

Focal Macular ERGs in Eyes after Removal of Macular ILM during Macular Hole Surgery Focal Macular ERGs in Eyes after Removal of Macular ILM during Macular Hole Surgery Hiroko Terasaki, Yozo Miyake, Ryoji Nomura, Chang-Hua Piao, Kenji Hori, Takashi Niwa, and Mineo Kondo PURPOSE. The removal

More information